Astera Labs, Inc. $ALAB Shares Acquired by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 94.6% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 109,576 shares of the company’s stock after purchasing an additional 53,276 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned approximately 0.07% of Astera Labs worth $9,908,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Freemont Management S.A. boosted its position in Astera Labs by 30.6% in the 2nd quarter. Freemont Management S.A. now owns 119,500 shares of the company’s stock valued at $10,805,000 after buying an additional 28,000 shares during the last quarter. Fox Run Management L.L.C. acquired a new position in shares of Astera Labs in the second quarter worth about $1,609,000. EFG Asset Management North America Corp. purchased a new position in Astera Labs in the second quarter valued at about $2,369,000. First Horizon Advisors Inc. grew its stake in Astera Labs by 12.4% during the 2nd quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock valued at $89,000 after purchasing an additional 108 shares in the last quarter. Finally, Ellevest Inc. grew its stake in Astera Labs by 69.5% during the 2nd quarter. Ellevest Inc. now owns 5,793 shares of the company’s stock valued at $524,000 after purchasing an additional 2,376 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Bank of America initiated coverage on Astera Labs in a research report on Friday, October 3rd. They issued a “neutral” rating and a $230.00 target price on the stock. Roth Capital lifted their price target on shares of Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Northland Capmk cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 22nd. Stifel Nicolaus increased their price objective on shares of Astera Labs from $185.00 to $200.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Finally, Zacks Research lowered shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th. Thirteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $181.59.

Insider Buying and Selling at Astera Labs

In related news, Director Manuel Alba sold 183,000 shares of the stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the sale, the director owned 385,863 shares in the company, valued at $66,858,482.01. This represents a 32.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jitendra Mohan sold 91,441 shares of the firm’s stock in a transaction dated Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the completion of the transaction, the chief executive officer directly owned 2,170,877 shares in the company, valued at $398,377,638.27. This represents a 4.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 434,480 shares of company stock worth $77,881,380. 12.50% of the stock is owned by company insiders.

Astera Labs Price Performance

Shares of ALAB opened at $157.79 on Thursday. The stock has a market capitalization of $26.65 billion, a PE ratio of 142.15, a price-to-earnings-growth ratio of 3.12 and a beta of 1.37. The business’s fifty day moving average price is $195.31 and its 200 day moving average price is $142.69. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The firm had revenue of $230.58 million during the quarter, compared to analyst estimates of $206.42 million. During the same quarter in the previous year, the firm earned $0.23 earnings per share. The firm’s revenue for the quarter was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, research analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.